Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
详细信息    查看全文
文摘

Frequencies of γδ T-cells are different in melanoma patients and controls.

Higher Vδ2+ and lower Vδ1+ T-cell levels in blood are prognostic for survival.

Decreasing Vδ2 cells during ipilimumab treatment is associated with poorer survival.

NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.